Hyderabad (Telangana) [India], May 17 (ANI): The DRDO's new anti-COVID drug 2DG is an add-on and not a substitute for any of the drugs that are used to treat coronavirus patients, said Deepak Sapra, the CEO of Pharmaceutical Services and API, Dr. Reddy's labs.
New Delhi [India], May 17 (ANI): Defence Minister Rajnath Singh on Monday lauded the Defence Research and Development Organisation (DRDO) for developing 2-deoxy-D-glucose (2-DG) drug for the treatment of COVID-19.
New Delhi [India], May 17 (ANI): The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh on Monday.
New Delhi [India], May 8 (ANI): The Defence Research and Development Organisation (DRDO)'s new anti-COVID drug, just approved by the Drugs Controller General of India (DCGI) is effective against different variants of the coronavirus and helps in bringing patients out of oxygen support, sa